PanOptica, Inc. Appoints Colin Goddard, Former CEO of OSI Pharmaceuticals, to Board of Directors
- 10:13 AM — Apr 1 —
- Source: Bioscience Technology
PanOptica, Inc., a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, is pleased to announce the appointment of Colin Goddard, PhD to its Board of Directors. Read More
PanOptica Raises $30 Million in Series A Financing and Licenses Lead Compound for Development as Topical Treatment of AMD
- 9:13 PM — Jan 4 —
- Source: Venture Capital News | Private Equity News
PanOptica, Inc., a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, today announced that it has raised $30 million in a Series A financing. Read More
Advertisement
Panoptica
On Sale
Hot Music News
Adam Levine Romancing New Model
Catwalk Queen Caught Kissing Rocker
Jessica's Shocking Sex Confession
Jessica Simpson's Bedroom Tell-All
Life After Living in the Kardashian Shadow
Singer Fights to Shake the Kardashian Curse
Infertility Struggles Revealed
Joe Nichols Opens Up About Baby Drama